Dose Escalation Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of BCD-132 in Patients With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT03551275 · COMPLETED
Trial details
- NCT number
- NCT03551275
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2018-10-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.